Goldman Sachs has introduced a new acronym, GRANOLAS, for European stocks comprising GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L'Oreal, LVMH, AstraZeneca, SAP, and Sanofi. These stocks have accounted for 60% of gains in the last year and have outperformed the Magnif 7 with half the volatility over the past two years. Another group of European stocks has also shown a significant rally in the last three years.
"Magnificent Sentiment": For The First Time In Years, Investors No Longer Expect A Recession As Everyone Piles Into Mag7 Stocks https://t.co/vjGTPHqFMF
Mag 7 stocks are as valuable as Japanese, French and U.K. stock market, combined https://t.co/MDrurAaojB
Europeβs equity market is dominated by a small group of internationally exposed quality growth compounders: the GRANOLAS (GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L'Oreal, LVMH, Astrazeneca, SAP and Sanofi). -GS https://t.co/XZLslnEZ0Q
Did you know that there's another group of stocks that has kept pace with the Mag 7? The largest companies in Europe have staged a rather impressive rally over the last three years as well! https://t.co/qVUoZzDwly
Goldman are at it again, a new acronym for European stocks: GRANOLAS GSK, Roche, ASML, Nestle, Novartis, Novo Nordisk, L'Oreal, LVMH, AstraZeneca, SAP &Sanofi - account for 60% of gains the last yr - have OUTPERFORMED Magnif 7 over the last 2 yrs with 1/2 the vol @cnbccharlotte